FDA Inspection 1032420 — Boris Alekseev
The FDA completed an inspection of Boris Alekseev on Oct 27, 2017 in Moscow. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 27, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Moscow (Russia)
Additional Details
Clinical Investigator (CI)